Amoclavs-LB (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Shreshtha Formulations (Sri Sai Pharma). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Amoxycillin, Clavulanic Acid,Lactic Acid Bacillus. This drug comes in the form of Syrup. The general packing available for this medicine consists of 30 ml and is priced at Rs 67 (arround $0.938 US Dollar)
The main active ingredients or salts in Amoclavs-LB (30 ml) are :
Amoxycillin-200 mg
Clavulanic Acid-28.5 mg
Lactic Acid Bacillus-40 million spores
Amoxycillin Indication (Prescribed for or used as): Respiratory, genito-urinary, skin and soft tissue, ENT infections due to susceptible strains of Gram negative organisms like H.influenzae, E-coli, P.mirabilis and N. gonorrhoea. Gram positive organisms like streptococci (including streptococcus faecalis) D. pneumoniae and non-penicillase producing staphylococci.
For more details on Amoxycillin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amoxycillin..
Clavulanic Acid Indication (Prescribed for or used as):
For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..
Lactic Acid Bacillus Indication (Prescribed for or used as):
For more details on Lactic Acid Bacillus, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Lactic Acid Bacillus..
Amoclavs-LB (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Amoclavs-LB (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Amoxycillin-200 mg Clavulanic Acid-28.5 mg Lactic Acid Bacillus-40 million spores). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.